This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (22)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Social Bookmarking   What's this?

Robert M. Tenery, Jr, MD

JAMA. 2000;283:391-393.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

My first formal contact with the health care technology industry was the black bag I received from a leading pharmaceutical company when I entered medical school. There were also gifts, such as penlights, notepads, and a multitude of drug samples, all with the pharmaceutical company's name clearly identified on the gift. Except for the occasional meeting with a pharmaceutical representative to discuss the advantages of a company's latest drug, that was the extent of our tangible relationship. The company name and product probably did achieve more recognition as a result. This, of course, is the lasting impact the company seeks.¹

Representatives from the health care industry can be a valuable information resource for physicians.^2-3 The potential for this information to help patients creates a responsibility on the part of the industry to share pertinent knowledge with physicians so that it can be used to raise . . . [Full Text of this Article]

Author Affiliation: Council on Ethical and Judicial Affairs, American Medical Association, Chicago, Ill.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?

JAMA. ;283():373-380.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Policies to Regulate Gifts to Physicians From Industry
Tsai
JAMA 2003;290:1776-1776.
FULL TEXT  

Influences on GPs' decision to prescribe new drugs--the importance of who says what
Prosser et al.
Fam Pract 2003;20:61-68.
ABSTRACT | FULL TEXT  

Physician-Industry Relations. Part 1: Individual Physicians
Coyle and for the Ethics and Human Rights Committee, America
ANN INTERN MED 2002;136:396-402.
ABSTRACT | FULL TEXT  

Physician-Industry Relations. Part 2: Organizational Issues
Coyle and for the Ethics and Human Rights Committee, America
ANN INTERN MED 2002;136:403-406.
ABSTRACT | FULL TEXT  

Separating Continuing Medical Education From Pharmaceutical Marketing
Relman
JAMA 2001;285:2009-2012.
FULL TEXT  

Gifts to Physicians From the Pharmaceutical Industry
Howard et al.
JAMA 2000;283:2655-2658.
FULL TEXT